TGTX - CIK 0001001316
The table below shows TG THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $442.21M | $74.08M | $129.13M | $132.14M | $195.82M | $82.91M |
| Short-term investments | $72.22M | $57.50M | $122.74M | $144.10M | $145.22M | $134.34M |
| Receivables | $392.05M | $265.38M | $231.52M | $190.12M | $115.73M | $83.61M |
| Inventory | $129.03M | $146.95M | $155.20M | $157.76M | $84.67M | $81.24M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.09B |
| $599.76M |
| $663.96M |
| $644.51M |
| $574.07M |
| $389.15M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.53B | $1.03B | $702.61M | $656.69M | $586.01M | $401.21M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $187.11M | $156.81M | $171.89M | $160.21M | $125.11M | $108.66M |
| Long-term debt | $745.14M | $245.34M | $245.04M | $244.73M | $244.16M | $102.54M |
| Total liabilities | $945.71M | $417.81M | $426.18M | $419.40M | $393.86M | $223.64M |
| Retained earnings | -$1.06B | -$1.11B | -$1.50B | -$1.52B | -$1.55B | -$1.56B |
| Total equity | $583.13M | $607.22M | $276.43M | $237.29M | $192.16M | $177.57M |